Gene · 445
Papers3,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Blood Vascular Endothelial Subtype-Specific Markers in Human Skin Unearthed by Single-Cell Transcriptomic Profiling. | Cells | 2022 | 35406678 | PubTator, text mining | PubMed |
| Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma. | Cells | 2022 | 35406630 | PubTator, text mining | PubMed |
| Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting. | PLoS One | 2022 | 35404966 | PubTator, text mining | PubMed |
| A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation. | Nat Commun | 2022 | 35393421 | PubTator, text mining | PubMed |
| The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum. | Alzheimers Dement (Amst) | 2022 | 35386474 | PubTator, text mining | PubMed |
| Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study. | Alzheimers Dement (Amst) | 2022 | 35386472 | PubTator, text mining | PubMed |
| Phosphorylated resveratrol as a protein aggregation suppressor in vitro and in vivo. | RSC Chem Biol | 2022 | 35360889 | PubTator, text mining | PubMed |
| CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease. | Neurobiol Dis | 2022 | 35358703 | PubTator, text mining | PubMed |
| Hallmarks of Metabolic Reprogramming and Their Role in Viral Pathogenesis. | Viruses | 2022 | 35337009 | PubTator, text mining | PubMed |
| Mitochondria as the Target of Hepatotoxicity and Drug-Induced Liver Injury: Molecular Mechanisms and Detection Methods. | Int J Mol Sci | 2022 | 35328737 | PubTator, text mining | PubMed |
| Plasma Metabolomic Profiling Reveals Four Possibly Disrupted Mechanisms in Systemic Sclerosis. | Biomedicines | 2022 | 35327409 | PubTator, text mining | PubMed |
| Metabolic Profiling of Thymic Epithelial Tumors Hints to a Strong Warburg Effect, Glutaminolysis and Precarious Redox Homeostasis as Potential Therapeutic Targets. | Cancers (Basel) | 2022 | 35326714 | PubTator, text mining | PubMed |
| Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy. | Cancers (Basel) | 2022 | 35326708 | PubTator, text mining | PubMed |
| Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression. | Clin Cancer Res | 2022 | 35325095 | PubTator, text mining | PubMed |
| Targeting Arginine in COVID-19-Induced Immunopathology and Vasculopathy. | Metabolites | 2022 | 35323682 | PubTator, text mining | PubMed |
| Identification of Novel Mutations in Chinese Infants With Citrullinemia. | Front Genet | 2022 | 35309121 | PubTator, text mining | PubMed |
| Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans. | EBioMedicine | 2022 | 35307406 | PubTator, text mining | PubMed |
| Molecular mechanisms of developmental pathways in neurological disorders: a pharmacological and therapeutic review. | Open Biol | 2022 | 35291879 | PubTator, text mining | PubMed |
| A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism. | PLoS Comput Biol | 2022 | 35286311 | PubTator, text mining | PubMed |
| Diagnosis of inborn errors of metabolism within the expanded newborn screening in the Madrid region. | JIMD Rep | 2022 | 35281663 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/papers?page=41